A recent survey reveals strong public backing in New Zealand for making respiratory syncytial virus vaccines publicly funded, as health groups and experts push for faster approval and access ahead of the winter season, amid ongoing pressure on hospitals.
A new survey suggests broad public backing in New Zealand for making respiratory syncytial virus vaccination publicly funded, as health groups and experts push for quicker access to protection ahead of winter.
RSV is a common virus that can cause cold-like symptoms, but it can also trigger severe lung and airway infections in babies and some older adults. In July, a briefing from the Public Health Communication Centre said a universal vaccination programme could free up thousands of hospital beds each year, underscoring the pressure the virus can place on the health system.
The Horizon Research online survey, carried out in early August among 1,028 adults and weighted to match the national population, found 70% supported public funding for RSV immunisation for eligible infants and vaccination during pregnancy. Only 9% were opposed. Support was strongest among respondents aged 65 and over and weaker among those aged 45 to 54, while higher education levels were linked with greater approval. Awareness of RSV was mixed, with 39% saying they had heard a great deal or a fair amount about it.
The findings come as the New Zealand Resident Doctors’ Association and the APEX Union call on the Ministry of Health and Pharmac to speed up approval, funding, purchasing and distribution of RSV vaccines. Health New Zealand’s immunisation guidance says RSVpreF is currently unfunded for older adults who meet eligibility criteria, while palivizumab is funded for infants at high risk of severe RSV disease. The Immunisation Advisory Centre says Arexvy is approved in New Zealand for certain older adults, and other campaigners have argued that pregnancy vaccines used in overseas trials should be made available more quickly.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
